141 related articles for article (PubMed ID: 38146232)
1. Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.
Campbell A; Teh B; Mulligan S; Ross DM; Weinkove R; Gilroy N; Gangatharan S; Prince HM; Szer J; Trotman J; Lane S; Dickinson M; Quach H; Enjeti AK; Ku M; Gregory G; Hapgood G; Ho PJ; Cochrane T; Cheah C; Greenwood M; Latimer M; Berkahn L; Wight J; Armytage T; Diamond P; Tam CS; Hamad N
Intern Med J; 2024 Feb; 54(2):328-336. PubMed ID: 38146232
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N
Intern Med J; 2021 May; 51(5):763-768. PubMed ID: 34047035
[TBL] [Abstract][Full Text] [Related]
3. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Weinkove R; McQuilten ZK; Adler J; Agar MR; Blyth E; Cheng AC; Conyers R; Haeusler GM; Hardie C; Jackson C; Lane SW; Middlemiss T; Mollee P; Mulligan SP; Ritchie D; Ruka M; Solomon B; Szer J; Thursky KA; Wood EM; Worth LJ; Yong MK; Slavin MA; Teh BW
Med J Aust; 2020 Jun; 212(10):481-489. PubMed ID: 32401360
[TBL] [Abstract][Full Text] [Related]
4. Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.
Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N
Intern Med J; 2020 Jun; 50(6):667-679. PubMed ID: 32415723
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement.
Furlong E; Kotecha RS; Conyers R; O'Brien TA; Hansford JR; Super L; Downie P; Eisenstat DD; Haeusler G; McMullan B; Phillips MB; Padhye B; Dalla-Pozza L; Alvaro F; Fraser CJ; Nicholls W; Clark JE; O'Connor M; Saxon BR; Tapp H; Heath J; Hunter SE; Tsui K; Winstanley M; Lyver A; Best EJ; Wadia U; Yeoh D; Blyth CC; Gottardo NG
Med J Aust; 2022 Apr; 216(6):312-319. PubMed ID: 35201615
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9).
Cesaro S; Ljungman P; Mikulska M; Hirsch HH; von Lilienfeld-Toal M; Cordonnier C; Meylan S; Mehra V; Styczynski J; Marchesi F; Besson C; Baldanti F; Masculano RC; Beutel G; Einsele H; Azoulay E; Maertens J; de la Camara R; ; Pagano L
Leukemia; 2022 Jun; 36(6):1467-1480. PubMed ID: 35488021
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
8. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Salmanton-García J; Marchesi F; Koehler P; Weinbergerová B; Čolović N; Falces-Romero I; Buquicchio C; Farina F; van Praet J; Biernat MM; Itri F; Prezioso L; Tascini C; Vena A; Romano A; Delia M; Dávila-Valls J; Martín-Pérez S; Lavilla-Rubira E; Adžić-Vukičević T; García-Bordallo D; López-García A; Criscuolo M; Petzer V; Fracchiolla NS; Espigado I; Sili U; Meers S; Erben N; Cattaneo C; Tragiannidis A; Gavriilaki E; Schönlein M; Mitrovic M; Pantic N; Merelli M; Labrador J; Hernández-Rivas JÁ; Glenthøj A; Fouquet G; Del Principe MI; Dargenio M; Calbacho M; Besson C; Kohn M; Gräfe S; Hersby DS; Arellano E; Çolak GM; Wolf D; Marchetti M; Nordlander A; Blennow O; Cordoba R; Mišković B; Mladenović M; Bavastro M; Limongelli A; Rahimli L; Pagano L; Cornely OA
Int J Antimicrob Agents; 2023 Oct; 62(4):106952. PubMed ID: 37582478
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Passamonti F; Cattaneo C; Arcaini L; Bruna R; Cavo M; Merli F; Angelucci E; Krampera M; Cairoli R; Della Porta MG; Fracchiolla N; Ladetto M; Gambacorti Passerini C; Salvini M; Marchetti M; Lemoli R; Molteni A; Busca A; Cuneo A; Romano A; Giuliani N; Galimberti S; Corso A; Morotti A; Falini B; Billio A; Gherlinzoni F; Visani G; Tisi MC; Tafuri A; Tosi P; Lanza F; Massaia M; Turrini M; Ferrara F; Gurrieri C; Vallisa D; Martelli M; Derenzini E; Guarini A; Conconi A; Cuccaro A; Cudillo L; Russo D; Ciambelli F; Scattolin AM; Luppi M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Olivieri A; Bocchia M; Gentile M; Marchesi F; Musto P; Federici AB; Candoni A; Venditti A; Fava C; Pinto A; Galieni P; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Visco C; Franchi M; Grossi PA; Bertù L; Corrao G; Pagano L; Corradini P;
Lancet Haematol; 2020 Oct; 7(10):e737-e745. PubMed ID: 32798473
[TBL] [Abstract][Full Text] [Related]
10. Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement.
Hamad N; Ananda-Rajah M; Gilroy N; MacIntyre R; Gottlieb D; Ritchie D; Harrison S; Kennedy G; Watson AM; Greenwood M; Doocey R; Perera T; Spencer A; Wong E; O'Brien T; Shaw P; Conyers R; Milliken S; Bardy P; Larsen S; Ho PJ; Lai H; Bajel A; Butler J; Tiley C; D'Rozario J; Johnston A; Cochrane T; Mills T; Irving I; Pullon H; Purtill D
Intern Med J; 2021 Aug; 51(8):1321-1323. PubMed ID: 34423546
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement.
Zaman S; MacIsaac AI; Jennings GL; Schlaich MP; Inglis SC; Arnold R; Kumar S; Thomas L; Wahi S; Lo S; Naismith C; Duffy SJ; Nicholls SJ; Newcomb A; Almeida AA; Wong S; Lund M; Chew DP; Kritharides L; Chow CK; Bhindi R
Med J Aust; 2020 Aug; 213(4):182-187. PubMed ID: 32734645
[TBL] [Abstract][Full Text] [Related]
12. Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
Shaw B; Shortt J; Low M; Rogers B; Kaplan Z; Fedele P; Gregory G; Vilcassim S; Gilbertson M; Grigoriadis G; Opat S
Intern Med J; 2022 Dec; 52(12):2172-2175. PubMed ID: 36436197
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
Sanchez-Pina JM; Rodríguez Rodriguez M; Castro Quismondo N; Gil Manso R; Colmenares R; Gil Alos D; Paciello ML; Zafra D; Garcia-Sanchez C; Villegas C; Cuellar C; Carreño-Tarragona G; Zamanillo I; Poza M; Iñiguez R; Gutierrez X; Alonso R; Rodríguez A; Folgueira MD; Delgado R; Ferrari JM; Lizasoain M; Aguado JM; Ayala R; Martinez-Lopez J; Calbacho M
Eur J Haematol; 2020 Nov; 105(5):597-607. PubMed ID: 32710500
[TBL] [Abstract][Full Text] [Related]
14. Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.
Cook LB; O'Dell G; Vourvou E; Palanicawandar R; Marks S; Milojkovic D; Apperley JF; Loaiza S; Claudiani S; Bua M; Hockings C; Macdonald D; Chaidos A; Pavlu J; Cooper N; Fidler S; Randell P; Innes AJ
Nat Commun; 2022 Nov; 13(1):6922. PubMed ID: 36376307
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study.
Oliva A; Curtolo A; Volpicelli L; Cancelli F; Borrazzo C; Cogliati Dezza F; Marcelli G; Gavaruzzi F; Di Bari S; Ricci P; Turriziani O; Mastroianni CM; Venditti M
Infection; 2022 Oct; 50(5):1373-1382. PubMed ID: 35781785
[TBL] [Abstract][Full Text] [Related]
16. Molnupiravir is effective in patients with haematological malignancies.
Bołkun Ł; Pula B; Kołkowska-Leśniak A; Morawska M; Cichocka E; Charlinski G; Garus B; Giebel S; Piszcz J; Drozd-Sokolowska J; Kwiatkowski J; Biernat M; Hus I; Lech-Maranda E; Długosz-Danecka M; Giannopoulos K; Wróbel T
Int J Cancer; 2023 Sep; 153(6):1251-1256. PubMed ID: 36691818
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
Glenthøj A; Jakobsen LH; Sengeløv H; Ahmad SA; Qvist K; Rewes A; Poulsen CB; Overgaard UM; Mølle I; Severinsen MT; Strandholdt CN; Maibom J; Kodahl AR; Ryg J; Ravn P; Johansen IS; Helsø SN; Jensen-Fangel S; Kisielewicz J; Wiese L; Helleberg M; Kirk O; Clausen MR; Frederiksen H
Eur J Haematol; 2021 Jan; 106(1):72-81. PubMed ID: 32939853
[TBL] [Abstract][Full Text] [Related]
18. Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study.
Oliva A; Cogliati Dezza F; Petrucci F; Romani FE; Morviducci M; Mirabelli FM; Cancelli F; Valeriani E; Marcelli G; Pugliese F; Turriziani O; Ricci P; Venditti M; Palange P; Mastroianni CM
Clin Exp Med; 2023 Oct; 23(6):2275-2285. PubMed ID: 36867292
[TBL] [Abstract][Full Text] [Related]
19. Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Mikulska M; Testi D; Russo C; Balletto E; Sepulcri C; Bussini L; Dentone C; Magne F; Policarpo S; Campoli C; Miselli F; Cilli A; Ghiggi C; Aquino S; Di Grazia C; Giannella M; Giacobbe DR; Vena A; Raiola AM; Bonifazi F; Zinzani P; Cavo M; Lemoli R; Angelucci E; Viale P; Bassetti M; Bartoletti M
Br J Haematol; 2023 May; 201(4):628-639. PubMed ID: 36806152
[TBL] [Abstract][Full Text] [Related]
20. Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET).
Body A; Ahern E; Lal L; Gillett K; Abdulla H; Opat S; O'Brien T; Downie P; Turville S; Munier CML; Smith C; MacIntyre CR; Segelov E
BMC Infect Dis; 2022 Jan; 22(1):70. PubMed ID: 35057745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
